Doctor says MDMA and psilocybin treatment will have a ‘significant’ impact

Australia’s medicine regulator will allow psychedelic substances to be prescribed to treat post-traumatic stress disorder and depression.

The Therapeutic Goods Administration (TGA) has given MDMA and psilocybin the green light from July.

The move makes Australia the first country in the world to officially recognise psychedelics as medicine.

Emergency medicine consultant and clinical drug researcher at the Australian National University, Dr David Caldicott, says the way the drugs can be used to treat PTSD and depression is “really quite remarkable and quite different to the way we’re used to talking about medicine”.

“I think this will have a significant impact in a group of patients for whom nothing really is working at the moment,” he told Neil Mitchell.

Press PLAY below to hear how the drugs will be used to treat PTSD and treatment resistant depression